Lucie Boyer
Overview
Explore the profile of Lucie Boyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murru A, Allard M, Pare G, Vaillancourt M, Boyer L, Cayer M, et al.
Front Med (Lausanne)
. 2022 Mar;
9:839475.
PMID: 35317326
Transfusion of granulocyte concentrates (GC) is an alternative therapy for neutropenic patients with life-threatening infections. While neutrophils are the main source of antimicrobial activity, only neutrophil numbers are used to...
2.
Dumont N, Boyer L, Emond H, Celebi-Saltik B, Pasha R, Bazin R, et al.
Exp Hematol
. 2014 May;
42(9):741-52.e1.
PMID: 24793546
Strategies to enhance the expansion of umbilical cord blood hematopoietic stem and progenitor cells (HSPCs) are crucial to enable their widespread application to adults and to overcome important limitations, such...
3.
Pineault N, Robert A, Cortin V, Boyer L
Methods Mol Biol
. 2012 Nov;
946:205-24.
PMID: 23179834
Megakaryocytes (MK) are hematopoietic cells present in the bone marrow that are responsible for the production and release of platelets in the circulation. Given their very low frequency (<1%), human...
4.
Emond H, Boyer L, Roy D, Pineault N
Stem Cells Dev
. 2012 Jul;
21(17):3209-19.
PMID: 22783996
Umbilical cord blood (UCB) transplantation is associated with prolonged periods of cytopenia. Ex vivo expansion of hematopoietic stem and progenitor cells (HSPCs) is currently investigated as a mean to accelerate...
5.
Tounkara F, Dumont N, Fournier S, Boyer L, Nadeau P, Pineault N
Stem Cells Dev
. 2012 May;
21(17):3197-208.
PMID: 22564002
Hyperthermia treatment has at times been associated with increased platelet levels in humans. The heat shock protein HSP70, which can be induced by hyperthermia in megakaryocytes and erythrocytes, was recently...
6.
Pineault N, Boyer L
Transfusion
. 2011 Nov;
51 Suppl 4:72S-81S.
PMID: 22074630
Background: Thrombocytopenia is a serious side effect following high-dose chemotherapy or whole-body irradiation. For many patients, a hematopoietic stem cell (HSC) transplant is required as part of the treatment or...
7.
Pineault N, Cortin V, Boyer L, Garnier A, Robert A, Therien C, et al.
Cytotherapy
. 2010 Nov;
13(4):467-80.
PMID: 21090916
Background Aims: Expansion of hematopoietic progenitors ex vivo is currently investigated as a means of reducing cytopenia following stem cell transplantation. The principal objective of this study was to develop...
8.
Leysi-Derilou Y, Robert A, Duchesne C, Garnier A, Boyer L, Pineault N
Cell Cycle
. 2010 Jul;
9(13):2589-99.
PMID: 20647776
Megakaryocytes (MK) undergo polyploidization through endomitosis, a mitotic process that ends prematurely due to aborted cytokinesis. To better understand this and other events associated with MK differentiation, we performed long-term...
9.
Robert A, Boyer L, Pineault N
Stem Cells Dev
. 2010 May;
20(3):379-90.
PMID: 20504152
The development of culture processes for hematopoietic progenitors could lead to the development of a complementary source of platelets for therapeutic purposes. However, functional characterization of culture-derived platelets remains limited,...
10.
Pineault N, Boucher J, Cayer M, Palmqvist L, Boyer L, Lemieux R, et al.
Stem Cells Dev
. 2008 Jun;
17(3):483-93.
PMID: 18522497
The physical culture parameters have important influences on the proliferation and differentiation fate of hematopoietic stem cells. Recently, we have demonstrated that CD34+ cord blood (CB) cells undergo accelerated and...